Trial
NCT02943733
Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Wisconsin, Madison
Collaborators
Taiho Pharmaceutical Co., Ltd.
Condition
Neuroendocrine Tumors
Intervention
TAS-102
Why stopped
closed per sponsor request, for slow enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-09-23